全球辐射剂量管理市场规模、份额、趋势和成长分析报告（2026-2034年）

预计辐射剂量管理市场规模将从 2025 年的 4.0032 亿美元成长到 2034 年的 14.5526 亿美元，2026 年至 2034 年的复合年增长率为 15.42%。

随着医疗专业人员日益重视提高影像检查中的病患安全，全球辐射剂量管理市场正稳定成长。辐射剂量管理系统有助于监测、追踪和优化电脑断层扫描、X光和透视等影像技术的辐射暴露。影像技术在疾病诊断中的日益普及也推动了该市场的扩张。

推动市场发展的主要因素是人们对过度辐射暴露潜在健康风险的认识不断提高。医院和诊断中心正在实施剂量管理软体，以确保符合安全法规并准确记录患者的辐射暴露。此外，许多国家日益严格的监管要求也促使医疗机构采用先进的监测系统。

随着医疗机构持续将病患安全和高品质医疗服务放在首位，辐射剂量管理市场预计将会扩张。影像设备和数据分析技术的进步将提升辐射水平的监测和控制能力。数位化医疗系统和医院整合软体的日益普及也将进一步推动市场成长。

目录

第一章：引言

第二章执行摘要

第三章 市场变数、趋势与框架

• 市场谱系展望
• 渗透率和成长前景分析
• 价值链分析
• 法律规范
  • 标准与合规性
  • 监管影响分析
• 市场动态
  • 市场驱动因素
  • 市场限制因素
  • 市场机会
  • 市场挑战
• 波特五力分析
• PESTLE分析

第四章 全球辐射剂量管理市场：依产品及服务划分

• 市场分析、洞察与预测
• 软体
• 服务

第五章 全球辐射剂量管理市场：依治疗方式划分

• 市场分析、洞察与预测
• 电脑断层扫描
• X光和乳房X光检查
• 透视和介入性影像
• 核子医学扫描
• 其他的

第六章 全球辐射剂量管理市场：依应用划分

• 市场分析、洞察与预测
• 肿瘤学
• 循环系统
• 整形外科
• 其他的

第七章 全球辐射剂量管理市场：依最终用户划分

• 市场分析、洞察与预测
• 医院
• 门诊部
• 研究机构
• 其他的

第八章 全球辐射剂量管理市场：依地区划分

• 区域分析
• 北美市场分析、洞察与预测
  • 我们
  • 加拿大
  • 墨西哥
• 欧洲市场分析、洞察与预测
  • 英国
  • 法国
  • 德国
  • 义大利
  • 俄罗斯
  • 其他欧洲国家
• 亚太市场分析、洞察与预测
  • 印度
  • 日本
  • 韩国
  • 澳洲
  • 东南亚
  • 其他亚太国家
• 拉丁美洲市场分析、洞察与预测
  • 巴西
  • 阿根廷
  • 秘鲁
  • 智利
  • 其他拉丁美洲国家
• 中东和非洲市场分析、洞察与预测
  • 沙乌地阿拉伯
  • UAE
  • 以色列
  • 南非
  • 其他中东和非洲国家

第九章 竞争情势

• 最新趋势
• 公司分类
• 供应链和销售管道合作伙伴（根据现有资讯）
• 市场占有率和市场定位分析（基于现有资讯）
• 供应商情况（基于现有资讯）
• 策略规划

第十章：公司简介

• 主要公司的市占率分析
• 公司简介
  • Landauer
  • Agfa-Gevaert Group
  • Sectra AB
  • Infinitt Healthcare Co. Ltd
  • Bayer AG
  • PACSHealth, LLC
  • Koninklijke Philips NV
  • GE Healthcare
  • Thermo Fisher Scientific Inc
  • Medsquare SAS
  • Siemens
  • Fujifilm Holdings Corporation
  • Qaelum NV

The Radiation Dose Management Market size is expected to reach USD 1455.26 Million in 2034 from USD 400.32 Million (2025) growing at a CAGR of 15.42% during 2026-2034.

The global radiation dose management market is growing steadily as healthcare providers focus on improving patient safety during medical imaging procedures. Radiation dose management systems help monitor, track, and optimize radiation exposure from imaging technologies such as CT scans, X-rays, and fluoroscopy. Increasing use of medical imaging for disease diagnosis is contributing to the expansion of this market.

A key driver of the market is the rising awareness about the potential health risks associated with excessive radiation exposure. Hospitals and diagnostic centers are implementing dose management software to ensure compliance with safety regulations and to maintain accurate records of patient radiation exposure. Additionally, growing regulatory requirements in many countries are encouraging healthcare facilities to adopt advanced monitoring systems.

In the future, the radiation dose management market is expected to expand as healthcare organizations continue to prioritize patient safety and quality care. Technological advancements in imaging equipment and data analytics will improve the ability to monitor and control radiation levels. The increasing adoption of digital healthcare systems and integrated hospital software will further support market growth.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Product and Services

• Software
• Services

By Modality

• Computed Tomography
• Radiography and Mammography
• Fluoroscopy and Interventional Imaging
• Nuclear Medicine Scan
• Others

By Application

• Oncology
• Cardiology
• Orthopedic
• Others

By End-user

• Hospitals
• Ambulatory Care Settings
• Research Organizations
• Others

COMPANIES PROFILED

• Landauer, AgfaGevaert Group, Sectra AB, Infinitt Healthcare Co Ltd, Bayer AG, PACSHealth, LLC, Koninklijke Philips NV, GE Healthcare, Thermo Fisher Scientific Inc, Medsquare SAS, Siemens, Fujifilm Holdings Corporation, Qaelum NV
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL RADIATION DOSE MANAGEMENT MARKET: BY PRODUCT AND SERVICES 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Product And Services
• 4.2. Software Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Services Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL RADIATION DOSE MANAGEMENT MARKET: BY MODALITY 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Modality
• 5.2. Computed Tomography Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Radiography and Mammography Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Fluoroscopy and Interventional Imaging Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.5. Nuclear Medicine Scan Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.6. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL RADIATION DOSE MANAGEMENT MARKET: BY APPLICATION 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast Application
• 6.2. Oncology Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Cardiology Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Orthopedic Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.5. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL RADIATION DOSE MANAGEMENT MARKET: BY END-USER 2022-2034 (USD MN)

• 7.1. Market Analysis, Insights and Forecast End-user
• 7.2. Hospitals Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.3. Ambulatory Care Settings Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.4. Research Organizations Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.5. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 8. GLOBAL RADIATION DOSE MANAGEMENT MARKET: BY REGION 2022-2034 (USD MN)

• 8.1. Regional Outlook
• 8.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.2.1 By Product And Services
  • 8.2.2 By Modality
  • 8.2.3 By Application
  • 8.2.4 By End-user
  • 8.2.5 United States
  • 8.2.6 Canada
  • 8.2.7 Mexico
• 8.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.3.1 By Product And Services
  • 8.3.2 By Modality
  • 8.3.3 By Application
  • 8.3.4 By End-user
  • 8.3.5 United Kingdom
  • 8.3.6 France
  • 8.3.7 Germany
  • 8.3.8 Italy
  • 8.3.9 Russia
  • 8.3.10 Rest Of Europe
• 8.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.4.1 By Product And Services
  • 8.4.2 By Modality
  • 8.4.3 By Application
  • 8.4.4 By End-user
  • 8.4.5 India
  • 8.4.6 Japan
  • 8.4.7 South Korea
  • 8.4.8 Australia
  • 8.4.9 South East Asia
  • 8.4.10 Rest Of Asia Pacific
• 8.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.5.1 By Product And Services
  • 8.5.2 By Modality
  • 8.5.3 By Application
  • 8.5.4 By End-user
  • 8.5.5 Brazil
  • 8.5.6 Argentina
  • 8.5.7 Peru
  • 8.5.8 Chile
  • 8.5.9 Rest of Latin America
• 8.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.6.1 By Product And Services
  • 8.6.2 By Modality
  • 8.6.3 By Application
  • 8.6.4 By End-user
  • 8.6.5 Saudi Arabia
  • 8.6.6 UAE
  • 8.6.7 Israel
  • 8.6.8 South Africa
  • 8.6.9 Rest of the Middle East And Africa

Chapter 9. COMPETITIVE LANDSCAPE

• 9.1. Recent Developments
• 9.2. Company Categorization
• 9.3. Supply Chain & Channel Partners (based on availability)
• 9.4. Market Share & Positioning Analysis (based on availability)
• 9.5. Vendor Landscape (based on availability)
• 9.6. Strategy Mapping

Chapter 10. COMPANY PROFILES OF GLOBAL RADIATION DOSE MANAGEMENT INDUSTRY

• 10.1. Top Companies Market Share Analysis
• 10.2. Company Profiles
  • 10.2.1 Landauer
  • 10.2.2 Agfa-Gevaert Group
  • 10.2.3 Sectra AB
  • 10.2.4 Infinitt Healthcare Co. Ltd
  • 10.2.5 Bayer AG
  • 10.2.6 PACSHealth, LLC
  • 10.2.7 Koninklijke Philips N.V
  • 10.2.8 GE Healthcare
  • 10.2.9 Thermo Fisher Scientific Inc
  • 10.2.10 Medsquare SAS
  • 10.2.11 Siemens
  • 10.2.12 Fujifilm Holdings Corporation
  • 10.2.13 Qaelum NV